This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Insights & Events

Filter

Content Type

Format

Service

Industry

Date

Showing 1-12 of 36 Search Results

Life Sciences

Inequities in patient support, well-being, and treatment access for triple negative breast cancer patients
- Reports
- August 12, 2022
Life Sciences

Strengthening regulatory systems in low- and middle-income countries: Improving the sustainability of the vaccine innovation ecosystem in Africa
- Reports
- July 13, 2022
Life Sciences

Should we screen for lung cancer? A 10-country analysis identifying key decision-making factors
- CRA Insights
- June 6, 2022
Life Sciences

A landscape assessment of newborn screening in Europe
- Articles
- April 4, 2022
Life Sciences Policy

Inequities in care and treatment for triple negative breast cancer patients
- Reports
- March 15, 2022
Life Sciences

How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)?
- Articles
- March 7, 2022
Life Sciences

An analysis of the effect of drug pricing provisions in the Build Back Better Act on pharmaceutical innovation
- Reports
- December 31, 2021
Life Sciences

PMPRB: Where do we go from here?
- CRA Insights
- December 9, 2021
Healthcare

Assessing the implications of centralized drug price setting to investment in clinical development for HIV treatments
- Reports
- December 1, 2021
Life Sciences

Supporting appropriate recognition and action for vaccination in AMR National Action Plans
- Reports
- November 22, 2021
Life Sciences

CRA Insights: A landscape assessment of newborn screening (NBS) in Europe
- CRA Insights
- November 16, 2021
Healthcare

Assessing the value of medicine for diverse patients: Implications of a QALY approach for health disparities
- Reports
- November 11, 2021